C46.4Kaposi's sarcoma of gastrointestinal sites

C46.4 is the ICD-10-CM diagnosis code for Kaposi's sarcoma of gastrointestinal sites. It belongs to category C46 (Kaposi's sarcoma), block C45-C49 (malignant neoplasms of mesothelial and soft tissue) and chapter 2 (neoplasms). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within C46 (Kaposi's sarcoma), C46.4 is specifically for Kaposi's sarcoma of gastrointestinal sites. Related codes cover of skin (C46.0), of soft tissue (C46.1), of palate (C46.2), of lymph nodes (C46.3), of lung (C46.5), of other sites (C46.7) and unspecified (C46.9).

Code first: any human immunodeficiency virus [HIV] disease (B20).

As a secondary diagnosis it is a CC (complication or comorbidity), which can move an inpatient stay into the "with CC" MS-DRG of its family, unless the principal diagnosis excludes it.

In MS-DRG v44.0, it is part of the grouping logic for DRG 374 (Digestive Malignancy with MCC, relative weight 2.1109), DRG 375 (Digestive Malignancy with CC, relative weight 1.1838), DRG 376 (Digestive Malignancy without CC/MCC, relative weight 0.8929), DRG 974 (HIV with Major Related Condition with MCC, relative weight 3.0506), DRG 975 (HIV with Major Related Condition with CC, relative weight 1.3252) and DRG 976 (HIV with Major Related Condition without CC/MCC, relative weight 0.8124), in MDC 06 (Diseases and Disorders of the Digestive System) and MDC 25 (Human Immunodeficiency Virus Infections), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.

Before ICD-10, this condition was coded in ICD-9-CM as 176.3 (Kaposi's sarcoma, gastrointestinal sites).